ChromoTek products set new benchmarks for cellular research. ChromoTek develops and markets Chromobody®-based live cell assays for drug screening and target validation. Other products include immunological and bioimaging reagents such as the GFP-Trap® for the rapid pull-down of GFP fusion proteins and GFP/ RFP Booster to amplify the fluorescent signal of GFP or RFP fusion proteins. ChromoTek’s fluorescence based protein-protein interaction assay, called Fluorescence-2-Hybrid (F2H), is available as screening service for commercial customers and as off the shelf kit for academic research. More than 4,500 customers from all over the world trust in ChromoTek products.


Actin Chromobody visualizes cytoskeletal microfilaments in different cell types derived from human, mouse and hamster.

Lamin Chromobody highlights nuclear lamin in live cells and enables monitoring of cellular fate over hours for high-content analysis and drug discovery.

Press releases

HTGF Exit ChromoTek

HTGF Exit ChromoTek
Successful exit for High-Tech Gründerfonds and Bayern Kapital –Proteintech acquires ChromoTek Proteintech, which is based in Chicago, Illinois, USA, is the benchmark in antibodiesMartinsried-based startup ChromoTek is a market leader in nanobodiesThe acquisition enables…

Capital for fluorescent mini-antibodies – new benchmarks in cell research

High-Tech Gründerfonds and Bayern Kapital are investing about EUR 400k in Chromotek GmbH. The investment is intended to fund research and development work aimed at ensuring successful market entry for chromobody technology in the field of living cell analysis. Chromotek GmbH, an enterprise spun off from the Ludwig…

Info & Contact

Dr. Marion Jung


Am Klopferspitz 19
82152 Planegg-Martinsried

400 Oser Ave Ste 1650
Hauppauge, NY 11788

In portfolio

27. Apr 2010 – 09. Oct 2020